ARCHIVES

Mace Rothenberg Leaves Vanderbilt For Pfizer Oncology.

This article is from The Cancer Letter archive.

Vol. 34 No. 42 | November 14, 2008

Download PDF Visit The Full Archive

Related Articles

GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL

July 26, 2013

What Should NCI Do When Center Directors Leave? Kimes Asks

July 24, 1992

NCAB Subcommittee Works On Drafting Quantitative Risk Assessment Policy

October 1, 1982

Compendium Drops Listing of Aranesp for Anemia of Cancer.

February 23, 2007

NCAB Votes to Bring Organ Systems Coordinating Center Into NCI, Disperse Entire Grants Portfolio

February 12, 1988

Frozen Section Analysis Helps Avoid Second Surgery

September 30, 2005